Evoq Remedies Past Earnings Performance
Past criteria checks 5/6
Evoq Remedies has been growing earnings at an average annual rate of 38.9%, while the Pharmaceuticals industry saw earnings growing at 14.8% annually. Revenues have been declining at an average rate of 47.5% per year. Evoq Remedies's return on equity is 5.5%, and it has net margins of 9.4%.
Key information
38.9%
Earnings growth rate
-6.7%
EPS growth rate
| Pharmaceuticals Industry Growth | 17.5% |
| Revenue growth rate | -47.5% |
| Return on equity | 5.5% |
| Net Margin | 9.4% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Evoq Remedies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 145 | 14 | 4 | 0 |
| 30 Jun 23 | 205 | 15 | 5 | 0 |
| 31 Mar 23 | 264 | 16 | 5 | 0 |
| 31 Dec 22 | 270 | 11 | 5 | 0 |
| 30 Sep 22 | 276 | 7 | 5 | 0 |
| 30 Jun 22 | 222 | 9 | 5 | 0 |
| 31 Mar 22 | 168 | 11 | 4 | 0 |
| 31 Mar 21 | 100 | 7 | 1 | 0 |
| 31 Mar 20 | 91 | 0 | 0 | 0 |
| 31 Mar 19 | 33 | 0 | 0 | 0 |
Quality Earnings: 543500 has high quality earnings.
Growing Profit Margin: 543500's current net profit margins (9.4%) are higher than last year (2.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 543500's earnings have grown significantly by 38.9% per year over the past 5 years.
Accelerating Growth: 543500's earnings growth over the past year (104.7%) exceeds its 5-year average (38.9% per year).
Earnings vs Industry: 543500 earnings growth over the past year (104.7%) exceeded the Pharmaceuticals industry 23.8%.
Return on Equity
High ROE: 543500's Return on Equity (5.5%) is considered low.